Phase I Clinical Trial of a Candidate HPV Vaccine

Clinical trial NCT05672966 · UNKNOWN

Trial details

NCT number: NCT05672966
Sponsor: Wuhan BravoVax Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Human Papillomavirus Infection

Start date: 2023-08-01
Primary completion: 2024-07-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.